Impact of Inter-Laboratory Variability on Model of End-Stage Liver Disease (MELD) Score Calculation

Area of Science:

• Hepatology
• Transplantation Medicine
• Clinical Chemistry

Background:

• The Model for End-Stage Liver Disease (MELD) score is crucial for assessing liver disease severity and prioritizing liver transplantation (LT).
• Germany implemented MELD-based organ allocation in 2006 to ensure equitable distribution of donor livers.
• Standardized laboratory testing is assumed for accurate MELD score calculation.

Purpose of the Study:

• To investigate the inter-laboratory variability of MELD score calculations in Germany.
• To assess the impact of different laboratories on MELD score accuracy for liver transplant allocation.
• To evaluate the comparability of laboratory results despite mandatory round-robin testing.

Main Methods:

• Blood samples from 10 liver disease patients were analyzed.
• Bilirubin, creatinine, and INR levels were measured in six distinct laboratories.
• MELD scores were calculated for each patient, and inter-laboratory variability was statistically analyzed.

Main Results:

• Significant inter-laboratory differences were observed for bilirubin, INR, and creatinine (p<0.05).
• The highest MELD score discrepancy between laboratories reached 5 points.
• Maximum inter-laboratory differences were 4.6 mg/dl for bilirubin, 1.2 mg/dl for INR, and 0.99 mg/dl for creatinine.

Conclusions:

• Nationwide liver allocation in Germany relies on non-comparable laboratory MELD score readouts.
• This variability poses a significant challenge to the accuracy and fairness of the MELD-based organ allocation system.
• Urgent need for standardization of laboratory testing to ensure reliable MELD scores for liver transplantation.